137 related articles for article (PubMed ID: 36530128)
1. Association Between HLA-DPB1 and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Children.
Gibson KM; Drögemöller BI; Foell D; Benseler SM; Graham J; Hancock REW; Luqmani RA; Cabral DA; Brown KL; Ross CJ;
Arthritis Rheumatol; 2023 Jun; 75(6):1048-1057. PubMed ID: 36530128
[TBL] [Abstract][Full Text] [Related]
2. HLA-DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Cohort Study.
Hilhorst M; Arndt F; Joseph Kemna M; Wieczorek S; Donner Y; Wilde B; Thomas Epplen J; van Paassen P; Cohen Tervaert JW
Arthritis Rheumatol; 2016 Jul; 68(7):1721-30. PubMed ID: 26866715
[TBL] [Abstract][Full Text] [Related]
3. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Merkel PA; Xie G; Monach PA; Ji X; Ciavatta DJ; Byun J; Pinder BD; Zhao A; Zhang J; Tadesse Y; Qian D; Weirauch M; Nair R; Tsoi A; Pagnoux C; Carette S; Chung S; Cuthbertson D; Davis JC; Dellaripa PF; Forbess L; Gewurz-Singer O; Hoffman GS; Khalidi N; Koening C; Langford CA; Mahr AD; McAlear C; Moreland L; Seo EP; Specks U; Spiera RF; Sreih A; St Clair EW; Stone JH; Ytterberg SR; Elder JT; Qu J; Ochi T; Hirano N; Edberg JC; Falk RJ; Amos CI; Siminovitch KA;
Arthritis Rheumatol; 2017 May; 69(5):1054-1066. PubMed ID: 28029757
[TBL] [Abstract][Full Text] [Related]
4. Association of
Kawasaki A; Sada KE; Kusumawati PA; Hirano F; Kobayashi S; Nagasaka K; Sugihara T; Ono N; Fujimoto T; Kusaoi M; Tamura N; Kusanagi Y; Itoh K; Sumida T; Yamagata K; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
Front Immunol; 2023; 14():1119064. PubMed ID: 36969218
[TBL] [Abstract][Full Text] [Related]
5. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
[TBL] [Abstract][Full Text] [Related]
6. PR3-ANCA-associated vasculitis is associated with a specific motif in the peptide-binding cleft of HLA-DP molecules.
Gregersen JW; Erikstrup C; Ivarsen P; Glerup R; Krarup E; Keller KK; Hansen IT; Møller BK
Rheumatology (Oxford); 2019 Nov; 58(11):1942-1949. PubMed ID: 30938436
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis.
Li W; Huang H; Cai M; Yuan T; Sheng Y
Front Immunol; 2021; 12():624848. PubMed ID: 33841406
[TBL] [Abstract][Full Text] [Related]
8. Risk HLA class II alleles and amino acid residues in myeloperoxidase-ANCA-associated vasculitis.
Wang HY; Cui Z; Pei ZY; Fang SB; Chen SF; Zhu L; Chen M; Chen N; Zhao MH
Kidney Int; 2019 Oct; 96(4):1010-1019. PubMed ID: 31471160
[TBL] [Abstract][Full Text] [Related]
9. Distinct HLA and non-HLA associations in different subtypes of ANCA-associated vasculitides in North India.
Singh J; Sharma A; Rani L; Kaur N; Anand S; Saikia B; Jha S; Nada R; Minz RW
Int J Rheum Dis; 2020 Jul; 23(7):958-965. PubMed ID: 32297471
[TBL] [Abstract][Full Text] [Related]
10. The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population.
Lundtoft C; Knight A; Meadows JRS; Karlsson Å; Rantapää-Dahlqvist S; Berglin E; Palm Ø; Haukeland H; Gunnarsson I; Bruchfeld A; Segelmark M; Ohlsson S; Mohammad AJ; Eriksson P; Söderkvist P; Ronnblom L; Omdal R; Jonsson R; Lindblad-Toh K; Dahlqvist J
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38580345
[TBL] [Abstract][Full Text] [Related]
11. Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease Activity.
Chen DP; McInnis EA; Wu EY; Stember KG; Hogan SL; Hu Y; Henderson CD; Blazek LN; Mallal S; Karosiene E; Peters B; Sidney J; James EA; Kwok WW; Jennette JC; Ciavatta DJ; Falk RJ; Free ME
J Am Soc Nephrol; 2022 Aug; 33(8):1517-1527. PubMed ID: 35672132
[TBL] [Abstract][Full Text] [Related]
12. Advances in the genomics of ANCA-associated vasculitis-a view from East Asia.
Kawasaki A; Tsuchiya N
Genes Immun; 2021 May; 22(1):1-11. PubMed ID: 33686257
[TBL] [Abstract][Full Text] [Related]
13. A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls.
Ince B; Kamali S; Bektaş M; Ögret YD; Savran FO; Yalçinkaya Y; Artim-Esen B; Inanç M; Öcal L; Gül A
Rheumatol Int; 2021 Sep; 41(9):1667-1672. PubMed ID: 33544216
[TBL] [Abstract][Full Text] [Related]
14. HLA-DPB1 variant rs3117242 is associated with anti-neutrophil cytoplasmic antibody-associated vasculitides in a Han Chinese population.
Wu Z; Wu Q; Xu J; Chen S; Sun F; Li P; Bai Y; Zheng W; Chen H; Zhang F; Li Y
Int J Rheum Dis; 2017 Aug; 20(8):1009-1015. PubMed ID: 26014903
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in ANCA-associated vasculitis: a meta-analysis.
Rahmattulla C; Mooyaart AL; van Hooven D; Schoones JW; Bruijn JA; Dekkers OM; ; Bajema IM
Ann Rheum Dis; 2016 Sep; 75(9):1687-92. PubMed ID: 26443607
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA.
Dahlqvist J; Ekman D; Sennblad B; Kozyrev SV; Nordin J; Karlsson Å; Meadows JRS; Hellbacher E; Rantapää-Dahlqvist S; Berglin E; Stegmayr B; Baslund B; Palm Ø; Haukeland H; Gunnarsson I; Bruchfeld A; Segelmark M; Ohlsson S; Mohammad AJ; Svärd A; Pullerits R; Herlitz H; Söderbergh A; Rosengren Pielberg G; Hultin Rosenberg L; Bianchi M; Murén E; Omdal R; Jonsson R; Eloranta ML; Rönnblom L; Söderkvist P; Knight A; Eriksson P; Lindblad-Toh K
Rheumatology (Oxford); 2022 Aug; 61(8):3461-3470. PubMed ID: 34888651
[TBL] [Abstract][Full Text] [Related]
17. Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Proteinase 3-Antineutrophil Cytoplasmic Antibody Vasculitides.
Brink M; Berglin E; Mohammad AJ; Lundquist A; Gjertsson I; Alexeyenko A; Lejon K; Rantapää-Dahlqvist S
Arthritis Rheumatol; 2023 Jun; 75(6):996-1006. PubMed ID: 36533851
[TBL] [Abstract][Full Text] [Related]
18. Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis.
Alberici F; Martorana D; Vaglio A
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i37-45. PubMed ID: 25523449
[TBL] [Abstract][Full Text] [Related]
19. Genetics of ANCA-associated vasculitides: HLA and beyond.
Alberici F; Martorana D; Bonatti F; Gioffredi A; Lyons PA; Vaglio A
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S90-7. PubMed ID: 24854378
[TBL] [Abstract][Full Text] [Related]
20. Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population: a genetic association study.
Kawasaki A; Namba N; Sada KE; Hirano F; Kobayashi S; Nagasaka K; Sugihara T; Ono N; Fujimoto T; Kusaoi M; Tamura N; Yamagata K; Sumida T; Hashimoto H; Ozaki S; Makino H; Arimura Y; Harigai M; Tsuchiya N
Arthritis Res Ther; 2020 Oct; 22(1):246. PubMed ID: 33076992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
